Amgen To Present At The 2021 Bank of America Merrill Lynch Healthcare Conference
Amgen will present at the 2021 Bank of America Merrill Lynch Virtual Healthcare Conference on May 11, 2021, at 11:00 a.m. ET. Key executives, including David M. Reese, M.D., Murdo Gordon, and Peter H. Griffith, will deliver presentations. The conference will be accessible via a live audio webcast for media, investors, and the public on Amgen's website. An archived version will be available for at least 90 days. Amgen focuses on developing innovative therapies for serious illnesses, leveraging human genetics since 1980.
- None.
- None.
THOUSAND OAKS, Calif., May 6, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Bank of America Merrill Lynch Virtual Healthcare Conference at 11:00 a.m. ET on Tuesday, May 11, 2021. David M. Reese, M.D., executive vice president of Research and Development, Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Michael Strapazon, 805-313-5553 (media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-2021-bank-of-america-merrill-lynch-healthcare-conference-301286114.html
SOURCE Amgen
FAQ
What time will Amgen present at the 2021 Bank of America Merrill Lynch Conference?
Who will represent Amgen at the 2021 healthcare conference?
How can I access Amgen's conference presentation?
Will there be a replay of the Amgen conference presentation?
What is Amgen's focus in biotechnology?
